Creegan & Nassoura Financial Group’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.37M | Sell |
10,920
-75
| -0.7% | -$9.55K | 0.89% | 40 |
|
|
2025
Q3 | $1.47M | Sell |
10,995
-950
| -8% | -$125K | 0.95% | 39 |
|
|
2025
Q2 | $1.62M | Sell |
11,945
-1,000
| -8% | -$132K | 1.06% | 35 |
|
|
2025
Q1 | $1.72M | Sell |
12,945
-175
| -1% | -$22.3K | 1.14% | 36 |
|
|
2024
Q4 | $1.48M | Sell |
13,120
-175
| -1% | -$20.2K | 1% | 37 |
|
|
2024
Q3 | $1.52M | Sell |
13,295
-175
| -1% | -$19.2K | 0.95% | 40 |
|
|
2024
Q2 | $1.4M | Sell |
13,470
-250
| -2% | -$26.5K | 0.96% | 39 |
|
|
2024
Q1 | $1.56M | Sell |
13,720
-20
| -0.1% | -$2.29K | 1.04% | 37 |
|
|
2023
Q4 | $1.51M | Hold |
13,740
| – | – | 1.1% | 37 |
|
|
2023
Q3 | $1.33M | Sell |
13,740
-125
| -0.9% | -$13.1K | 1.04% | 40 |
|
|
2023
Q2 | $1.51M | Sell |
13,865
-87
| -0.6% | -$9.27K | 1.12% | 38 |
|
|
2023
Q1 | $1.41M | Hold |
13,952
| – | – | 1.08% | 38 |
|
|
2022
Q4 | $1.53M | Hold |
13,952
| – | – | 1.19% | 35 |
|
|
2022
Q3 | $1.35M | Hold |
13,952
| – | – | 1.17% | 35 |
|
|
2022
Q2 | $1.52M | Buy |
13,952
+1
| +0% | +$114 | 1.27% | 36 |
|
|
2022
Q1 | $1.65M | Sell |
13,951
-14
| -0.1% | -$1.74K | 1.24% | 33 |
|
|
2021
Q4 | $1.97M | Sell |
13,965
-425
| -3% | -$54.4K | 1.49% | 30 |
|
|
2021
Q3 | $1.7M | Sell |
14,390
-274
| -2% | -$33.7K | 1.45% | 27 |
|
|
2021
Q2 | $1.7M | Sell |
14,664
-374
| -2% | -$43.6K | 1.45% | 31 |
|
|
2021
Q1 | $1.8M | Sell |
15,038
-463
| -3% | -$54.9K | 1.61% | 28 |
|
|
2020
Q4 | $1.7M | Buy |
15,501
+1
| +0% | +$109 | 1.63% | 28 |
|
|
2020
Q3 | $1.69M | Hold |
15,500
| – | – | 1.82% | 23 |
|
|
2020
Q2 | $1.42M | Sell |
15,500
-294
| -2% | -$26.6K | 1.6% | 27 |
|
|
2020
Q1 | $1.25M | Sell |
15,794
-74
| -0.5% | -$6.17K | 1.63% | 27 |
|
|
2019
Q4 | $1.38M | Buy |
+15,868
| New | +$1.33M | 1.39% | 33 |
|
|
2016
Q3 | $886K | Buy |
20,948
+1
| +0% | +$43 | 1.03% | 44 |
|
|
2016
Q2 | $823K | Buy |
20,947
+1
| +0% | +$40 | 0.97% | 47 |
|
|
2016
Q1 | $876K | Sell |
20,946
-1,149
| -5% | -$45.5K | 1.04% | 43 |
|
|
2015
Q4 | $992K | Buy |
22,095
+1
| +0% | +$44 | 1.13% | 41 |
|
|
2015
Q3 | $889K | Sell |
22,094
-150
| -0.7% | -$7.07K | 1.01% | 47 |
|
|
2015
Q2 | $1.09M | Buy |
22,244
+1
| +0% | +$48 | 1.14% | 41 |
|
|
2015
Q1 | $1.03M | Sell |
22,243
-699
| -3% | -$32.1K | 1.06% | 44 |
|
|
2014
Q4 | $1.03M | Buy |
+22,942
| New | +$999K | 1.05% | 44 |
|
Other funds holding ABT
JSC
Creegan & Nassoura Financial Group's ABT Position: Q4 2025 in Review
Creegan & Nassoura Financial Group reduced its Abbott (ABT) stake by 0.68% in Q4 2025, selling an estimated $9.55K and leaving 10,920 shares worth $1.37M. The position accounts for 0.89% of the portfolio, ranked #40.
Creegan & Nassoura Financial Group first reported a position in ABT in Q4 2014 and has held it in 33 quarters since. The position peaked at $1.97M in Q4 2021. 3,276 funds tracked by Wall St. Rank hold ABT as of Q4 2025.
- Creegan & Nassoura Financial Group held 10,920 shares of Abbott worth $1.37M as of Q4 2025.
- Creegan & Nassoura Financial Group sold 75 Abbott shares in Q4 2025, an estimated $9.55K.
- Abbott made up 0.89% of Creegan & Nassoura Financial Group's portfolio in Q4 2025, its #40 holding.
- Creegan & Nassoura Financial Group first reported a position in Abbott in Q4 2014 and has held it in 33 quarters since.
- Creegan & Nassoura Financial Group's Abbott position peaked at $1.97M in Q4 2021.
- 3,276 funds tracked by Wall St. Rank held Abbott as of Q4 2025.
Based on Creegan & Nassoura Financial Group's 13F filing for Q4 2025, filed 17 Feb 2026.